Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Yubo International Biotech Limited (YBGJ) had Tangible Shareholders Equity of $-1.65M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-0.28M |
|
-- |
|
-- |
|
$0.31M |
|
$-0.31M |
|
$0.00M |
|
$-0.31M |
|
$-0.31M |
|
$-0.31M |
|
$-0.31M |
|
$-0.31M |
|
$-0.31M |
|
$-0.31M |
|
$-0.27M |
|
147.87M |
|
147.87M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$0.65M |
|
$0.08M |
|
$0.30M |
|
$0.95M |
|
$2.56M |
|
-- |
|
-- |
|
$2.56M |
|
$-1.60M |
|
|
Tangible Shareholders Equity |
$-1.65M |
$-1.60M |
|
170.42M |
|
| Cash Flow Statement Financials | |
$-0.71M |
|
$0.08M |
|
$0.47M |
|
$0.01M |
|
$0.01M |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.25 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.63M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
19.36% |
|
18.85% |
|
-32.54% |
|
19.36% |
|
$-0.01 |
|
$-0.00 |
|
$-0.00 |
|